AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 96 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,828,000 | -12.1% | 550,000 | 0.0% | 0.14% | -8.8% |
| Q1 2021 | $4,356,000 | +0.6% | 550,000 | 0.0% | 0.15% | +6.5% |
| Q4 2020 | $4,329,000 | +11.0% | 550,000 | 0.0% | 0.14% | +3.0% |
| Q3 2020 | $3,900,000 | -23.3% | 550,000 | 0.0% | 0.14% | -39.7% |
| Q2 2020 | $5,088,000 | – | 550,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $891,000 | 15.31% |
| Aisling Capital Management LP | 1,691,151 | $13,445,000 | 2.68% |
| GREAT POINT PARTNERS LLC | 900,000 | $7,155,000 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $22,639,000 | 1.40% |
| Altium Capital Management LP | 609,689 | $4,847,000 | 1.27% |
| Sio Capital Management, LLC | 446,000 | $3,546,000 | 1.13% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,953,000 | 1.12% |
| Samsara BioCapital, LLC | 883,720 | $7,026,000 | 1.10% |
| Lion Point Capital, LP | 300,000 | $2,385,000 | 0.45% |
| Abingworth LLP | 240,500 | $1,912,000 | 0.43% |